Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Asthma

Study Title
A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
Teva Identifier
ABS-AS-201
ClinicalTrials.gov Identifier
NCT01058863
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
12 Years and older
Trial Duration
02/01/2010 - 06/01/2010
Phase
Phase 2

Study Type

Interventional